Your browser doesn't support javascript.
loading
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
Lawler, Mark; Davies, Lynne; Oberst, Simon; Oliver, Kathy; Eggermont, Alexander; Schmutz, Anna; La Vecchia, Carlo; Allemani, Claudia; Lievens, Yolande; Naredi, Peter; Cufer, Tanja; Aggarwal, Ajay; Aapro, Matti; Apostolidis, Kathi; Baird, Anne-Marie; Cardoso, Fatima; Charalambous, Andreas; Coleman, Michel P; Costa, Alberto; Crul, Mirjam; Dégi, Csaba L; Di Nicolantonio, Federica; Erdem, Sema; Geanta, Marius; Geissler, Jan; Jassem, Jacek; Jagielska, Beata; Jonsson, Bengt; Kelly, Daniel; Kelm, Olaf; Kolarova, Teodora; Kutluk, Tezer; Lewison, Grant; Meunier, Françoise; Pelouchova, Jana; Philip, Thierry; Price, Richard; Rau, Beate; Rubio, Isabel T; Selby, Peter; Juznic Sotlar, Maja; Spurrier-Bernard, Gilliosa; van Hoeve, Jolanda C; Vrdoljak, Eduard; Westerhuis, Willien; Wojciechowska, Urszula; Sullivan, Richard.
Affiliation
  • Lawler M; Patrick G Johnston Centre for Cancer Research, Faculty of Medicine, Health and Life Sciences, Queen's University Belfast, Belfast, UK. Electronic address: mark.lawler@qub.ac.uk.
  • Davies L; International Cancer Research Partnership, International House, Cardiff, UK.
  • Oberst S; Organisation of European Cancer Institutes, Brussels, Belgium.
  • Oliver K; International Brain Tumour Alliance, Tadworth, UK; European Cancer Organisation Patient Advisory Committee, Brussels, Belgium.
  • Eggermont A; Faculty of Medicine, Utrecht University Medical Center, Utrecht, Netherlands; Princess Máxima Centrum, Utrecht, Netherlands.
  • Schmutz A; International Agency for Cancer Research, Lyon, France.
  • La Vecchia C; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Allemani C; Cancer Survival Group, London School of Hygiene & Tropical Medicine, London, UK.
  • Lievens Y; Department of Radiation Oncology, Ghent University and Ghent University Hospital, Ghent, Belgium.
  • Naredi P; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Cufer T; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Aggarwal A; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK; Institute of Cancer Policy, King's College London, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Aapro M; Genolier Cancer Center, Genolier, Switzerland.
  • Apostolidis K; Hellenic Cancer Federation, Athens, Greece; European Cancer Patient Coalition, Brussels, Belgium.
  • Baird AM; Lung Cancer Europe, Bern, Switzerland; Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
  • Cardoso F; Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
  • Charalambous A; European Cancer Organisation Brussels, Brussels, Belgium; Department of Nursing, Cyprus University of Technology, Limassol, Cyprus; Department of Oncology, University of Turku, Turku, Finland.
  • Coleman MP; Cancer Survival Group, London School of Hygiene & Tropical Medicine, London, UK.
  • Costa A; European School of Oncology, Milan, Italy.
  • Crul M; Amsterdam UMC, Amsterdam, Netherlands.
  • Dégi CL; Faculty of Sociology and Social Work, Babeș-Bolyai University, Cluj-Napoca, Romania.
  • Di Nicolantonio F; Department of Oncology, University of Turin, Turin, Italy; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Erdem S; European Cancer Organisation Patient Advisory Committee, Europa Donna, Istanbul, Türkiye.
  • Geanta M; Centre for Innovation in Medicine and Kol Medical Media, Bucharest, Romania.
  • Geissler J; Patvocates and CML Advocates Network, Leukaemie-Online (LeukaNET), Munich, Germany.
  • Jassem J; Medical University of Gdansk, Gdansk, Poland.
  • Jagielska B; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Jonsson B; Stockholm School of Economics, Stockholm, Sweden.
  • Kelly D; School of Healthcare Sciences, Cardiff University, Cardiff, UK.
  • Kelm O; International Agency for Research on Cancer, Lyon, France.
  • Kolarova T; International Neuroendocrine Cancer Alliance, Boston, MA, USA.
  • Kutluk T; Faculty of Medicine & Cancer Institute, Hacettepe University, Ankara, Türkiye.
  • Lewison G; Institute of Cancer Policy, School of Cancer Sciences, Kings College London, London, UK.
  • Meunier F; Belgian Royal Academy of Medicine, Brussels, Belgium.
  • Pelouchova J; Diagnoza leukemie, Prague, Czech Republic.
  • Philip T; Organisation of European Cancer Institutes, Brussels, Belgium; Institut Curie, Paris, France.
  • Price R; European Cancer Organisation Brussels, Brussels, Belgium.
  • Rau B; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Rubio IT; Cancer Center, University of Navarra, Madrid, Spain.
  • Selby P; School of Medicine, University of Leeds, Leeds, UK.
  • Juznic Sotlar M; EuropaColon Slovenia, Ljubljana, Slovenia.
  • Spurrier-Bernard G; Melanoma Patient Network Europe, Brussels, Belgium.
  • van Hoeve JC; Organisation of European Cancer Institutes, Brussels, Belgium; Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.
  • Vrdoljak E; Department of Oncology, University Hospital Center Split, School of Medicine, University of Split, Split, Croatia.
  • Westerhuis W; Organisation of European Cancer Institutes, Brussels, Belgium; Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.
  • Wojciechowska U; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Sullivan R; Institute of Cancer Policy, School of Cancer Sciences, Kings College London, London, UK.
Lancet Oncol ; 24(1): e11-e56, 2023 01.
Article in En | MEDLINE | ID: mdl-36400101
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Guideline / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Guideline / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article